Empirically supported treatments for panic disorder with agoraphobia in a spanish psychology clinic journal

  1. Ballesteros, Francisco
  2. Labrador Encinas, Francisco Javier
Revista:
The Spanish Journal of Psychology

ISSN: 1138-7416

Año de publicación: 2014

Volumen: 17

Páginas: 1-8

Tipo: Artículo

DOI: 10.1017/SJP.2014.65 DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: The Spanish Journal of Psychology

Resumen

The aim of this work is to study the sociodemographic and clinical characteristics of patients diagnosed with Panic Disorder with Agoraphobia (PD/Ag), as well as the characteristics of the treatment and its results and cost in a University Psychology Clinic. Fifty patients demanded psychological assistance for PD/Ag; 80% were women, with an average age of 29.22 years (SD = 9.03). Mean number of evaluation sessions was 3.26 (SD = 1.03), and of treatment sessions, 13.39 (SD = 9.237). Of the patients, 83.33% were discharged (that is, questionnaire scores were below the cut-off point indicated by the authors, and no PD/Ag was observed at readministration of the semistructured interview), 5.5% refused treatment, and 11% were dropouts. The average number of treatment sessions of patients who achieved therapeutic success was 15.13 (SD = 8.98). Effect sizes (d) greater than 1 were obtained in all the scales. Changes in all scales were significant (p < .05). The estimated cost of treatment for patients who achieved therapeutic success was 945.12�. The treatment results are at least similar to those of studies of efficacy and effectiveness for PD/Ag. The utility of generalizing treatments developed in research settings to a welfare clinic is discussed.

Referencias bibliográficas

  • Addis M. E., Hatgis C., Krasnow A. D., Jacob K., Bourne L., & Mansfield A. (2004). Effectiveness of cognitive-behav ioral treatment for panic disorder versus treatment as usual in a managed care setting. Journal of Consulting and Clinical Psychology, 72, 625-635. http://dx.doi.org/10.1037/0022-006X.72.4.625
  • American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th Ed., Rev.). Washington, DC: Author.
  • Bados A. (2009). Agorafobia y pánico [Agoraphobia and panic]. Barcelona, Spain. Universidad de Barcelona.
  • Bakker A., van Balkom, M. D., Anton J. L. M., & van Dyck R. (2000). Selective serotonin reuptake inhibitors in the treatment of panic disorder and agoraphobia. Internati onal Clinical Psychopharmacology, 15, 25-30.
  • Baldwin D. S., Anderson I. M., Nutt D. J., Bandelow B., Bond A., Davidson J. R., ⋯ Wittchen H. U. (2005). Evidence-based guidelines for the pharmacologica l treatment of anxiety disorders: Recommendations from the British association for psychopharmacology. Journal of Psychopharmacology, 19, 567-596. http://dx.doi.org/10.1177/0269881105059253
  • Barlow D. H., & Cras ke M. G. (1994). Mastery of your anxiety and panic-II. San Antonio, TX: The Psychological Corporation.
  • Barlow D. H., Craske M. G., Cerny J. A., & Klosko J. S. (1989). Behavioral treatment for panic disorder. Behavior Therapy, 20, 261-282. http://dx.doi.org/10.1016/S0005-7894(89)80073-5
  • Barlow D. H., Esler J. L., & Vitali A. E. (2008). Psychosocial treatment for panic disorder, phobias and generalized anxiety disorder. In P. E. Nathan & J. M. Gorman (Eds.), A guide to treatments that work (pp. 288-318). New York, NY: Oxford University Press.
  • Boletín Oficial Del Estado (2007). Orden SCO/3867/2007, p or la que se determina los nuevos conjuntos de medicamentos y sus precios [Order SCO/3867/2007, establishing new sets of drugs and their prices]. (BOE Publication No. 312) Spain. Retrieved from http://www.boe.es/boe/dias/2007/12/29/pdfs/A53 846-53890.pdf
  • Beck A. T.,Steer R. A.,Brown G. K. 1996). Manual for the Beck Depression Inventory-II. San Antonio, TX Psychological Corporation.
  • Bravo M. F. (2002). Psicofármacos para psicólogos [Psychotropic drugs for psychologists]. Madrid, Spain. Síntesis.
  • Chambless D. L., Baker M. J., Baucom D. H., Beutler L. E, Calhoun K. S., Crits-Christoph P., Woody S. R. (1998). Update on empirically validated th erapies II. The Clinical Psychologist, 51(1), 3-16.
  • Chambless D. L., Caputo G. C., Bright P., & Gallagher R. (1984). Assessment of fear of fear in agoraphobics: The Body Sensations Questionnaire and the Agoraphobic Cognitions Questionnaire. Journal of Consulting and Clinical Psychology, 52, 1090-1097. http://dx.doi.org/10.1037/0022-006X.52.6.1090
  • Clark D. M. (1989). Anxiety states: Panic and generalized anxiety. In K. Hawton, P. M. Salkovskis, J. Kirk, & D. M. Clark (Eds.), Cognitive behavior therapy for psychiatric problems. A practical guide (pp. 52-96). Oxf ord, UK: Oxford University Press.
  • Clark D. M., Salkovskis P. M., Hackman A., Middleton H., Anastasiades P., & Gelder M. (1994). A comparison of cognitive therapy, applied relaxation and imipramine the t reatment of panic disorder. British Journal of Psychiatric, 164, 759-769. http://dx.doi.org/10.1192/bjp.164.6.759
  • Cohen J. (1988). Statistical power analysis for the behavioral sciences (2nd Ed.). Hillsdale, NJ: Elrbaum.
  • Comeche M. I., Díaz M. I., & Vallejo M. A. (1995). Cuestionarios, inventarios y escalas: Ansiedad, depresión, habilidades sociales [Questionnaires, inventories and scales: Anxiety, depression, social skills]. Madrid, Spain: Fundación Universidad-Empresa.
  • Craske M. G., & Barlow D. H. (2007). Mastery of your anxiety and panic: Therapy guide (4th Ed.). London, UK: Oxford University Press.
  • Hahlweg K., Fiegenbaum W., Frank M., Schroeder B., & von Witzleben I. (2001). Short and long term effectiveness of an e mpirically supported treatment for agoraphobia. Journal of Consulting and Clinical Psychology, 69, 375-382. http://dx.doi.org/10.1037/0022-006X.69.3.375
  • Heuzenroeder L., Donnelly M., Haby M. M, Mihalopoulos C., Rossele R., Andrews G., & Vos T. (2004). Cost-effectiveness of psychological interventions for generalized anxiety and panic disorder. Australian & New Zealand Journal of Psychiatry, 38, 602-612. http://dx.doi.org/10.1111/j.1440-1614.2004.01423.x
  • Kenardy J., Dow M. G., Johnston D. W., Newman M. G., Thomson A., & Taylor C. B. (2003). A comparison of delivery of cognitive-behavioral therapy for panic disor der: An international multicenter trial. Journal of Consulting and Clinical Psychology, 71, 1068-1075. http://dx.doi.org/10.1037/0022-006X.71.6.1068
  • Labrador F. J., & Ballesteros F. (2011). Efectividad de los tratamientos para la fobia social en elá mbito aplicado [Effectiveness of treatments for social phobia in an applied setting]. Psicothema, 23, 560-565.
  • Labrador F. J., Estupiña F. J., & García-Vera M. P. (2010). Demanda de atención psicológica en práctica clínica: Tratamiento y resultados [Psychological care demand in clinical practice: Treatment and results]. Psicothema, 22, 619-626.
  • Ministerio de Sanidad y Consumo (2006). Pr opuesta de estrategia en salud mental Del Sistema Nacional de Salud [Proposal of mental health strategy of the National Health System]. Madrid, Spain: Ministerio de Consumo, Centro de Publicaciones.
  • Mitte K. (2005). A meta-Ana lysis of the efficacy of psychoand pharmacotherapy in panic disorder with and without agoraphobia. Journal of Affective Disorder, 88, 27-45. http://dx.doi.org/10.1016/j.jad.2005.05.003
  • Muñoz M. (2003). Manual práctico de evaluación psicológica clínica [Practical handbook of clinical psychological assessment]. Madrid, Spain: Síntesis.
  • Ö st L-G., Thulin U., & RamneröJ. (2004). Cognitive behavior therapy vs. exposure in vivo in t reatment of panic disorder with agoraphobia. Behaviour Research and Therapy, 42, 1105-1127. http://dx.doi.org/10.1016/j.brat.2003.07.004
  • Otto M. W., Pollack M. H., & Maki K. M. (2000). Empirically suppo rted treatments for panic disorder: Costs, benefits and stepped care. Journal of Consulting and Clinical Psychology, 68, 556-563. http://dx.doi.org/10.1037/0022-006X.68.4.556
  • Rosenberg M. K., & Hougaard E. (2005). Cognitivebehavioral group treatment of panic disorder and agoraphobia in a psychiatric setting: A naturalistic study of effectiveness. Nordic Journal of Psychiatry, 59, 198-204. http://dx.doi.org/10.1080/0803948051002767 0
  • Ruhmland M., & Margraf J. (2001). Efficacy of psychological therapy for panic and agoraphobia: Meta-Analysis of the level of troubles. Verhaltenstherapie, 11, 41-53. http://dx.doi.org/10.1159/000050323
  • Sanz J.,Perdigón L. A.,Vázquez C. 2003 Adaptación española Del Inventario para la Depresión de Beck-II (BDI-II 2. Propiedades psicométricas en población general [Spanish adaptation of the Beck Depression Inventory-II (BDI-II): Psychometric pr operties in general population]. Clínica y Salud 14 249-280.
  • Van Apeldoorn F., van Hout W., Mersch P., Huisman M., Slaap B., Hale W., ⋯ den Boer J. A. (2008). Is a combined therapy more effective t han either CBT or SSRI alone? Result of a multicenter trial on panic disorder with or without agoraphobia. Acta Psychiatrica Scandinavica, 117, 260-270. http://dx.doi.org/10.1111/j.1600-0447.2008.01157.x
  • Wade W. A., Treat T. A., & Stuart G. L. (1998). Transporting an empirically supported treatment for panic disorder to a service clinic setting: A benchmarking strategy. Journal of Consulting Clinic Psychology, 66, 231-239. http://dx.doi.org/10.1037/0022-006X.66.2.231
Fuente de los datos: Dialnet